Full-Time

Pharmaceutical Field Sales Representative

Posted on 5/12/2026

Inizio Engage

Inizio Engage

501-1,000 employees

Provides integrated data insights for pharma

No salary listed

Riverside, CA, USA

In Person

Category
Sales & Account Management (1)
Required Skills
Lead Generation
Cold Calling
Requirements
  • 2-4 years of pharma focused on primary care call points is preferred (with desire to be in rare disease)
  • Comparable and/or strong B2B experience with desire to get into pharma (device, diagnostics background)
  • Cold Calling experience in health care or previous work experience
  • Experience with office-based selling in complex model of referral-health-care-providers to prescriber-health-care-providers in newly created market
  • Experience working in a field team model with account managers
  • Must maintain a high level of knowledge within the disease state and product labeling
  • Must be accountable for their individual performance
  • A heavy volume of coldcalling on all targeted health care providers is a requirement
Responsibilities
  • Achieve territory/primary market results measured in referrals and new prescriptions in assigned geography
  • Driving demand through clinical selling and education to referring and treating Generalists focusing on identifying patients in their care, including cold calling on key accounts and gaining access and key insights
  • Profile accounts and edit lead list to ensure correct targets are being reached with appropriate frequency
  • Validate HCP has a child eligible for therapy
  • Edit Account list data and assist with segmentation exercises as assigned
  • Provide account feedback to leadership regarding market intelligence
  • Deployed in key markets with highest potential and take on primary and secondary market approach to maximize reach and frequency
  • Reps accountable for tracking activities in CRM system (reach and frequency)
  • Deliver approved educational messaging where relevant
  • Drive awareness of the product among assigned targeted HCPs
  • Assist client with understanding of how and when an HCP would refer a patient
  • Disease state and product education to referring HCPs
  • Validating office has a patient (connecting Account Manager with office/family via opt ins)
  • Must be accountable for their individual performance
  • Heavy volume of cold calling on all targeted health care providers is a requirement
Desired Qualifications
  • Pediatrics/Generalists experience strongly preferred
  • Experience in rare disease exposure or interest (implied by desire to be in rare disease)

Inizio Engage turns scattered data into integrated insights and learning solutions for the pharmaceutical and biotechnology sectors. Its PROPENSITY4 data platform combines data from multiple sources to support decision making across customer needs, commercial operations, and strategic goals. The ecosystem includes Ashfield Excellence Academy, Axiom, Cormis, and Logicearth, which provide training, communications, and capability-building programs for pharma commercial and medical teams. By pairing data analytics with targeted training and talent development, the company helps patients, healthcare professionals, and pharmaceutical firms improve outcomes and gain competitive advantages.

Company Size

501-1,000

Company Stage

N/A

Total Funding

N/A

Headquarters

Upper Dublin Township, Pennsylvania

Founded

N/A

Simplify Jobs

Simplify's Take

What believers are saying

  • Nazaré Access Academy addresses growing US patient access complexity for pharma.
  • PROPENSITY4 transforms disparate data into integrated insights for commercial optimization.
  • Strategic leadership appointments signal potential for streamlined operations and market expansion.

What critics are saying

  • Nazaré brand consolidation cannibalizes legacy divisions' revenue within 6-12 months.
  • IQVIA's integrated platforms directly compete with PROPENSITY4's data analytics services.
  • AI-powered learning platforms displace human-led training, halving demand by 2028.

What makes Inizio Engage unique

  • End-to-end commercialization partner spanning discovery through post-launch lifecycle.
  • Integrated suite connecting medical affairs, data insights, and creative engagement capabilities.
  • 5,000+ professionals across 20+ countries delivering localized pharmaceutical expertise globally.

Help us improve and share your feedback! Did you find this helpful?

Your Connections

People at Inizio Engage who can refer or advise you

Benefits

Private Medical Insurance

Life Insurance

Pension Scheme

Hybrid Work Options

Paid Vacation

401(k) Retirement Plan

Company News

PMLiVE
Dec 11th, 2025
Inizio Engage CEO Jim Sage featured in pharmaphorum's "12 Questions" series

Inizio Engage CEO Jim Sage featured in pharmaphorum's "12 Questions" series. Discover Jim Sage's insights on leadership, industry challenges, and the transformative impact of data, technology, and patient-centric innovation in his latest pharmaphorum "12 Questions" interview. We're pleased to share that Jim Sage, Global CEO and President of Inizio Engage, has been featured in pharmaphorum's latest "12 Questions" interview series. In the conversation, Jim reflects on his career across international markets, his motivations as a leader, and the experiences that have shaped his approach to building high-performing teams. He also explores some of the most pressing challenges facing the pharmaceutical industry today, including pricing pressures, launch performance, and the need for new reimbursement models. Jim highlights how data, technology, and AI are already transforming the way organisations operate, and discusses the growing importance of patient-centric approaches, from HUB services to personalised support throughout the treatment journey. This content was provided by Inizio Discover Jim Sage's insights on leadership, industry challenges, and the transformative impact of data, technology, and patient-centric innovation in his latest pharmaphorum "12 Questions" interview. As the understanding of obesity continues to evolve, so too does the science, patient experience, and cross-sector collaboration driving innovation. At ObesityWeek(R) 2025 in Atlanta, experts from across Inizio reflected... Discover how our DataGateway platform unifies fragmented real-world oncology data into a single, validated dataset that delivers deeper insights and faster decision-making. Inizio today announced the launch of InConcert(TM), a new AI-powered data solution designed to accelerate smarter, evidence-led decisions during the critical pre-launch phase of the product lifecycle. Discover key insights from ESMO 2025 on how design, emotion, and sustainability are reshaping medical congress experiences. Featuring expert takes from Inizio leaders. As the global hematology community prepares for the 67th ASH(R) Annual Meeting and Exposition, Inizio experts share their perspectives on what's driving the field forward - and how pharma companies... At Inizio Medical, we believe AI isn't replacing Medical Affairs - it's redefining what's possible. Our platform, iON.AI(TM), enhances human expertise, streamlines complex workflows, and strengthens strategic impact through seamless... Discover how Inizio experts are shaping the future of obesity care - where science, strategy, and innovation unite to advance cardiometabolic health and drive real-world impact. At Fierce Pharma Week, Inizio revealed how the fusion of human expertise and purposeful AI is reshaping pharma communications and driving real-world impact - discover how this human-centered innovation is defining the... Inizio is leading the way in Intelligent Commercialization(TM) by uniting proprietary AI-powered platforms, deep scientific expertise, and proven governance to unlock measurable, lasting value at every stage of commercialization. * 1 * 2 * 3 * 4 * 5 * 6 * 7 * 8 * 9 * 10 * 11 * 12 * 13 * 14 * 15 * 16 * 17 * 18 * 19 * 20 * 21 * 22 * 23 * 24 * 25 * 26 * 27 * 28 * 29 * 30 * 31 * 32 * 33 * 34 * 35 * 36 * 37 * 38 * 39 * 40 * 41 * 42 * 43 * 44 * 45 * 46 * 47 * 48 * 49 * 50

PMLiVE
Sep 24th, 2025
Inizio celebrates six finalist honors at the 2025 PM360 Trailblazer Awards

We're proud to announce that our teams across Inizio Evoke, Inizio Engage, and Inizio Medical have been named finalists in six prestigious categories at the 2025 PM360 Trailblazer Awards, which recognize excellence and innovation in healthcare marketing.

Bdaily
Sep 14th, 2025
Inizio names new chief executive

Inizio, a global commercialisation partner to health and life sciences companies, has appointed Ryan Quigley as chief executive.

Inizio Engage
Mar 5th, 2025
Inizio Engage choose Egg as Patient Support Program implementation partner in Italy.

After a review of potential Patient Support Program (PSP) partners in Italy, Inizio Engage has formed a collaboration with Egg, head quartered in Milan.

Haymarket Media
Feb 12th, 2025
The Escalator: Pfizer, Vertex Pharmaceuticals, Inizio and more

Inizio announced that Remco op den Kelder has been appointed to the president of Inizio Advisory and Jim Sage will become president of Inizio Engage.